Ofole Mgbako, MD
NYU Langone Health, Departments of Medicine and Population Health - Assistant Professor
NYC Health + Hospitals/Bellevue, Division of Infectious Diseases - Section Chief
NYU Institute for Excellence in Health Equity - Clinical Pillar Lead
NYC Health + Hospitals/Bellevue, Division of Infectious Diseases - Section Chief
NYU Institute for Excellence in Health Equity - Clinical Pillar Lead
Email: Ofole.Mgbako@nyulangone.org
Education
MD, Perelman School of Medicine, University of PennsylvaniaBA, History and Literature, Harvard College
Research Interests
HIV, Stigma, Adherence, Viral suppression, Racial minorities, Gender minorities, MSM, Health equity, Health disparities BIO
Ofole Mgbako is an assistant professor of Medicine and Population Health at NYU Langone Health, Section Chief of Infectious Diseases at Bellevue Hospital and Co-Clinical Pillar Lead of the NYU Institute for Excellence in Health Equity. Prior to medical school, he worked for the Center for Urban Epidemiological Studies at the New York Academy of Medicine, the American Foundation for AIDS Research (amfAR), and worked on various HIV-related global health projects in Ghana, Jamaica and South Africa. During residency training at NYU Langone, he was part of the Dr. Dustin Duncan’s Spatial Epidemiology Lab. Dr. Mgbako completed his infectious diseases fellowship at Columbia University and a postdoctoral research fellowship at the HIV Center for Clinical and Behavioral Studies. Dr. Mgbako’s research focuses on biobehavioral interventions and outcomes for racial, gender and sexual minorities along the HIV care continuum. He is interested in the impact of interventions such as immediate antiretroviral therapy (iART) and novel technologies on retention in care, ART adherence and viral load suppression among marginalized populations. Dr. Mgbako is also interested in how trauma, intersectional stigma, structural racism and homophobia impact HIV-related outcomes. Projects
Principal Investigator, Mixed Methods Study to Understand Sociostructural Predictors of Severe Mpox Outcomes, Intersectional Stigma, and Substance Use Among Patients with Co-Morbid HIV in NYC. Active
Principal Investigator, Rapid ART and HIV Care Engagement Among Young Black and Latinx Sexual and Gender Minorities with HIV: A Mixed Methods Study. Active
Publications
Recent
Ferraris CM, D'avanzo PA, Jennings L, Robbins RN, Nguyen N, Leu CS, Dolezal C, Mgbako O, Hsiao NY, Joska J, Castillo-Mancilla JR, Myer L, Anderson PL, Belaunzaran-Zamudio PF, Mellins CA, Orrell C, Remien RH (2023).
Acceptability and feasibility of providing adherence feedback based on tenofovir diphosphate in dried blood spots: Results from a pilot study among patients and providers in Cape Town, South Africa
AIDS and Behavior, 27 (10), 3478-3486. doi: 10.1007/s10461-023-04063-7. PMCID: PMC10811583.
Acceptability and feasibility of providing adherence feedback based on tenofovir diphosphate in dried blood spots: Results from a pilot study among patients and providers in Cape Town, South Africa
AIDS and Behavior, 27 (10), 3478-3486. doi: 10.1007/s10461-023-04063-7. PMCID: PMC10811583.
Mgbako O, Loughran C, Mathu R, Castor D, McLean J, Sobieszczyk ME, Olender S, Gordon P, Lopez-Rios J, Remien RH (2023).
Rapid or immediate ART, HIV stigma, medical mistrust, and retention in care: An exploratory mixed methods pilot study
AIDS and Behavior, 27 (10), 3430-3446. doi: 10.1007/s10461-023-04058-4. PMCID: PMC10111080.
Rapid or immediate ART, HIV stigma, medical mistrust, and retention in care: An exploratory mixed methods pilot study
AIDS and Behavior, 27 (10), 3430-3446. doi: 10.1007/s10461-023-04058-4. PMCID: PMC10111080.
Kaul CM, Moore BE, Kaplan-Lewis E, Casey E, Pitts RA, Pagan Pirallo P, Lim S, Kapadia F, Cohen GM, Khan M, Mgbako O (2023).
EquiPrEP: An implementation science protocol for promoting equitable access and uptake of long-acting injectable HIV pre-exposure prophylaxis (LAI-PrEP)
PLoS One, 18 (9), e0291657. doi: 10.1371/journal.pone.0291657. PMCID: PMC10508596.
EquiPrEP: An implementation science protocol for promoting equitable access and uptake of long-acting injectable HIV pre-exposure prophylaxis (LAI-PrEP)
PLoS One, 18 (9), e0291657. doi: 10.1371/journal.pone.0291657. PMCID: PMC10508596.
Chan J, DiTullio DJ, Pagan Pirallo P, Foote M, Knutsen D, Kottkamp AC, McPherson TD, Mukherjee V, Pitts R, Wallach A, Wong M, Mazo D, Mgbako O (2023).
Implementation and early outcomes of a telehealth visit model to deliver tecovirimat for mpox infection in New York City
Journal of Telemedicine and Telecare [Epub 2023 Aug 25]. doi: 10.1177/1357633X231194796.
Implementation and early outcomes of a telehealth visit model to deliver tecovirimat for mpox infection in New York City
Journal of Telemedicine and Telecare [Epub 2023 Aug 25]. doi: 10.1177/1357633X231194796.
Jennings L, Ferraris CM, Castillo-Mancilla JR, Robbins RN, Nguyen N, Leu CS, Dolezal C, Hsiao NY, Mgbako O, Joska J, Myer L, Anderson PL, Remien RH, Orrell C, ADD-ART Team (2023).
Comparing predictive ability of two objective adherence measures in a community-based cohort on antiretroviral therapy in South Africa: Tenofovir diphosphate concentrations and electronic adherence monitors
Journal of Acquired Immune Deficiency Syndromes, 93 (4), 327-332. doi: 10.1097/QAI.0000000000003198. PMCID: PMC10287050.
Comparing predictive ability of two objective adherence measures in a community-based cohort on antiretroviral therapy in South Africa: Tenofovir diphosphate concentrations and electronic adherence monitors
Journal of Acquired Immune Deficiency Syndromes, 93 (4), 327-332. doi: 10.1097/QAI.0000000000003198. PMCID: PMC10287050.
Notable
Transactional sex and preferences for pre-exposure prophylaxis (PrEP) administration modalities among men who have sex with men (MSM)
Journal of Sex Research, 56 (4-5), 650-658. doi: 10.1080/00224499.2018.1449190. PMCID: PMC6179954.
Dr. Mgbako's Google Scholar Profile
Selected Press